- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
000739
SHZ
Week ended 07 Aug 2026
Weekly Investor Report
Apeloa Pharmaceutical Co.,Ltd · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
23.41 CNY
15.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 31.6% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 15.8%, after a 30.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
75
out of 100
Latest Close
23.41 CNY
7 Aug 2026
1W Return
15.8%
latest completed week
4W Return
30.1%
short-term follow-through
12W Return
41.0%
quarterly tape
Trend Breadth
84.6%
44 of 52 weeks active
Volume Ratio
2.1x
vs 13-week average
- Activity pressure is weak, so confirmation is not yet broad enough.
- 4 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.8%
Latest completed week; four-week move 30.1%.
Indicator stack
60/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 31.6% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 15.8%, after a 30.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4012-week average 0.41
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.40Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 30.1% over four weeks, 41.0% over 12 weeks, and 51.5% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year44
Trend breadth84.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.40Latest activity-pressure read.
Pressure change355.5%Four-week change in activity pressure.
Leadership33.90Latest relative-leadership reading.
RS change2724.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown0.0%Distance below the 52-week high.
13-week volatility6.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+15.8%Week of 7 Aug.
Worst week-8.2%Week of 20 Mar.
Latest week+15.8%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains10
Flat weeks0
Modest losses9
Sharp losses3
Recent vol6.3%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank2 / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Drug Manufacturers - Specialty & Generic
4-week rank3 / 100
Group average5.1%
Trend breadth11.0%
Trend11.0%active weekly trend signals
MD69.0%positive activity pressure
RS18.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape71/100
Trend, activity pressure, participation, and risk combine to a 71/100 tape read.
Indicator analysis31/100Latest 12-week confirmation: trend 5/12, activity pressure 4/12, relative leadership 4/12.
Activity pressure 0.40; 4 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Apeloa Pharmaceutical Partners with Jitai Technology for CDMO Business Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 23.41 CNY | 15.8% | 17.78 CNY | 15.13 CNY | 1.40 | 33.90 | 146.4M | On |
| 31 Jul 2026 | 20.22 CNY | 2.7% | 17.54 CNY | 15.08 CNY | 1.08 | 22.33 | 87.8M | On |
| 24 Jul 2026 | 19.68 CNY | 0.2% | 17.40 CNY | 15.06 CNY | 0.76 | 17.56 | 117.3M | On |
| 17 Jul 2026 | 19.65 CNY | 9.2% | 17.30 CNY | 15.03 CNY | 0.11 | 18.12 | 172.6M | On |
| 10 Jul 2026 | 18.00 CNY | -1.3% | 17.18 CNY | 15.01 CNY | -0.55 | -1.29 | 66.2M | Off |
| 3 Jul 2026 | 18.24 CNY | 14.3% | 17.11 CNY | 15.00 CNY | -1.02 | -3.71 | 19.8M | Off |
| 26 Jun 2026 | 15.96 CNY | -2.5% | 17.03 CNY | 14.99 CNY | -1.41 | -16.91 | 6.6M | Off |
| 19 Jun 2026 | 16.37 CNY | 1.9% | 17.02 CNY | 15.00 CNY | -1.39 | -16.54 | 24.9M | Off |
| 12 Jun 2026 | 16.07 CNY | -0.4% | 16.99 CNY | 15.00 CNY | -1.24 | -12.73 | 9.0M | Off |
| 5 Jun 2026 | 16.13 CNY | -2.9% | 16.95 CNY | 15.01 CNY | -1.01 | -14.78 | 7.8M | Off |
| 29 May 2026 | 16.61 CNY | -1.8% | 16.93 CNY | 15.02 CNY | -0.80 | -14.10 | 47.3M | Off |
| 22 May 2026 | 16.91 CNY | 1.9% | 16.88 CNY | 15.03 CNY | -0.55 | -13.02 | 69.8M | On |
| 15 May 2026 | 16.60 CNY | -5.3% | 16.84 CNY | 15.04 CNY | -0.36 | -14.70 | 114.7M | On |
| 8 May 2026 | 17.52 CNY | -4.1% | 16.82 CNY | 15.05 CNY | -0.31 | -10.29 | 37.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.